PlumX Metrics
Embed PlumX Metrics

Effective ankaferd hemostat treatment for severe intractable chronic deep leg ulcer associated with behçet’s disease

Archives of Rheumatology, ISSN: 2618-6500, Vol: 34, Issue: 4, Page: 457-460
2019
  • 0
    Citations
  • 0
    Usage
  • 7
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

Ankaferd hemostat (Ankaferd Blood Stopper; ABS) is a pro-hemostatic agent affecting erythrocytes. In this article, we report a 50-year-old male patient who presented with a non-healing leg ulcer for one year. He had a past medical history of Behçet’s disease (BD) diagnosed at the age of 29 and therapy was started. Patient's leg ulcer did not respond to any treatment. Topical ABS was applied to the patient's leg ulcer daily. Our experience suggested that local treatment of ABS can be a potentially successful therapy for the management of intractable or incurable chronic ulcers in patients with BD or for other ischemic or vasculitic skin problems.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know